EU issues guidance on how to factor genetic variations into drug development
13 February 2012
Ian Schofield
Please Login to read the full article.
13 February 2012
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- Avanir gains rights to Concert's 'heavy' Nuedexta dextromethorphan
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
- Cyprotex's gADME offers personalised dosing opportunities
- EMA validates Gilead's application for HIV drug booster agent cobicistat
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
